Eupraxia Pharmaceuticals is trading 11.1% up at $7.00 in after-hours trading with no clear catalyst identified for the move.

  • The stock moved sharply higher from its regular-session close of $6.30.
  • No fresh earnings, FDA, M&A, or major news reports have been released to explain the jump.
  • The price action may reflect thin after-hours liquidity or smaller orders having an outsized impact rather than a disclosed company event.